Alnylam Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Alnylam: Analysts See A Star On The Rise
Article By: TipRanks
Thursday, September 6, 2018 4:37 AM EDT
Biopharma company Alnylam Pharmaceuticals has built a brand on its innovative RNAi therapeutics. Alnylam landed on Forbes’ ‘100 Most Innovative Growth Companies’ list.
In this article: ALNY
Read
3 ‘Strong Buy’ Stocks You Need On Your Investing Radar
Article By: TipRanks
Tuesday, August 7, 2018 1:44 PM EDT
Top analysts just can’t get enough of these three hot stocks.
In this article: ALNY, ATVI, LRCX
Read
5 Of The Best-Performing Biotech Stocks Of 2017
Article By: Arpita Dutt
Sunday, December 31, 2017 3:46 PM EDT
2017 turned out to be a pretty good year for the biotech sector. The sector had been struggling due to the drug pricing controversy, mixed results, slower-than-expected new product launches, increasing competition and pipeline setbacks.
In this article: XOMA, DVAX, SGMO, ALNY, BLUE, PFE, GILD
Read
E Large Cap Stocks: Gainers And Losers In 2017
Article By: Arie Goren
Saturday, December 30, 2017 12:24 PM EDT
Here are the best and the worst performers among Russell 1000 stocks in 2017, and 20 stocks that have a chance to perform well in 2018, which should be another good year for investors in large cap stocks.
In this article: AN, LEN, OPK, RAD, RRC, UHS, ALNY, SBNY, EXAS, BLUE, ESNT, EVHC, SQ, UAA, OLED Also: IWB
Read
4 Biotech Stocks That More Than Doubled This Year
Article By: Zacks Investment Research
Saturday, December 23, 2017 7:50 PM EDT
The biotech industry has been on the comeback trail in 2017 after facing challenges including pricing pressure, rising competition, pipeline setbacks, pricing pressure, slowdown in growth of mature products and generic competition for key drugs.
In this article: JUNO, BLUE, XOMA, PBYI, PIRS, ALNY Also: CELG
Read

PARTNER HEADLINES

Latest Tweets for $ALNY

No tweets yet!